13 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Neuralstem, Inc. CUR shares surged 25.9% to $1.65 during Wednesday's pre-market session. The market cap stands at $3.4 million.
• Microbot Medical, Inc. MBOT shares increased by 13.5% to $5.62. The market cap stands at $28.1 million.
• Bionano Genomics, Inc. BNGO stock increased by 11.4% to $0.83. The market cap seems to be at $7.8 million.
• Galapagos, Inc. GLPG shares moved upwards by 3.5% to $181.97. The most recent rating by Morgan Stanley, on October 29, is at Overweight, with a price target of $193.00.
• Fresenius Medical Care, Inc. FMS stock increased by 3.4% to $35.87. According to the most recent rating by Redburn, on October 23, the current rating is at Neutral.
• Johnson & Johnson, Inc. JNJ shares moved upwards by 2.8% to $132.75. The market cap stands at $340.3 billion. The most recent rating by Credit Suisse, on October 24, is at Outperform, with a price target of $163.00.
• Ionis Pharmaceuticals, Inc. IONS stock surged 2.3% to $56.00. The market cap seems to be at $8.6 billion. The most recent rating by Morgan Stanley, on October 11, is at Equal-Weight, with a price target of $63.00.
• AstraZeneca, Inc. AZN shares surged 1.5% to $48.28.
• GlaxoSmithKline, Inc. GSK stock surged 1.3% to $45.16. According to the most recent rating by New Street, on October 16, the current rating is at Hold.
• Alcon, Inc. ALC shares surged 1.1% to $58.73. The most recent rating by Credit Suisse, on August 26, is at Outperform, with a price target of $73.00.
• Bristol-Myers Squibb, Inc. BMY shares rose 1.1% to $56.40. The market value of their outstanding shares is at $81.8 billion. The most recent rating by UBS, on October 23, is at Neutral, with a price target of $53.00.

Losers

• Catalyst Pharmaceuticals, Inc. CPRX stock plummeted 12.3% to $5.00 during Wednesday's pre-market session. The market cap seems to be at $545.5 million.
• Novartis, Inc. NVS stock fell 1.3% to $87.24.